These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25742516)

  • 1. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
    Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Hunt PM; Rudel R; Sathyanarayana S; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
    Andrology; 2016 Jul; 4(4):565-72. PubMed ID: 27003928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
    Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
    Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.
    Hunt PA; Sathyanarayana S; Fowler PA; Trasande L
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1562-70. PubMed ID: 27003299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
    Attina TM; Hauser R; Sathyanarayana S; Hunt PA; Bourguignon JP; Myers JP; DiGangi J; Zoeller RT; Trasande L
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):996-1003. PubMed ID: 27765541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cost burden of exposure to endocrine disrupting chemicals. A critical review.
    Bond GG; Dietrich DR
    Arch Toxicol; 2017 Aug; 91(8):2745-2762. PubMed ID: 28528477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor: Re: Neurobehavioral Deficits, Diseases, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union.
    Middelbeek RJ; Veuger SA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L52-3. PubMed ID: 26047084
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease burden attributable to endocrine-disrupting chemicals exposure in China: A case study of phthalates.
    Cao Y; Li L; Shen K; Liu J
    Sci Total Environ; 2019 Apr; 662():615-621. PubMed ID: 30699382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impacts of environmentally attributable childhood health outcomes in the European Union.
    Bartlett ES; Trasande L
    Eur J Public Health; 2014 Feb; 24(1):21-6. PubMed ID: 23748596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.
    Grandjean P; Bellanger M
    Environ Health; 2017 Dec; 16(1):123. PubMed ID: 29202828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to the Letter by Middlebeek and Veuger.
    Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
    J Clin Endocrinol Metab; 2015 Jun; 100(6):L54-5. PubMed ID: 26047085
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan.
    Prichystalova R; Fini JB; Trasande L; Bellanger M; Demeneix B; Maxim L
    Environ Health; 2017 Jun; 16(1):55. PubMed ID: 28599657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs.
    Malits J; Naidu M; Trasande L
    Toxics; 2022 Mar; 10(3):. PubMed ID: 35324771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
    Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population attributable risks and costs of diabetogenic chemical exposures in the elderly.
    Trasande L; Lampa E; Lind L; Lind PM
    J Epidemiol Community Health; 2017 Feb; 71(2):111-114. PubMed ID: 27789757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
    Matthiessen P; Johnson I
    Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Environmental Disruptor Chemicals in the Development of Non Communicable Disease.
    Zarean M; Poursafa P
    Adv Exp Med Biol; 2019; 1121():21-31. PubMed ID: 31392649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.